Skip to main content
TipRanks
Go Ultimate75% OFF

Maxigen Biotech Inc. (1783) Cash flow

Maxigen Biotech Inc. Cash Flow

TW:1783's free cash flow for Q2 2026 was NT$57.74M. For the 2026 fiscal year, TW:1783's free cash flow was decreased by NT$-17.01M and operating cash flow was NT$74.75M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 290.22MNT$ 298.22MNT$ 171.20MNT$ 268.34MNT$ 117.59M
NT$ -382.99MNT$ -29.07MNT$ -490.25MNT$ 10.43MNT$ -2.77M
NT$ 30.66MNT$ -59.73MNT$ -41.39MNT$ -1.05MNT$ 188.69M
NT$ 576.19MNT$ 639.05MNT$ 431.08MNT$ 790.95MNT$ 513.30M
NT$ 207.59MNT$ 266.45MNT$ 148.76MNT$ 253.90MNT$ 102.15M

Currency in TWD

Maxigen Biotech Inc. Cash Flow

-600M-400M-200M0200M400M201720182019202020212022202320242025OperatingInvestingFinancing